During the past decade, Seoul National University Boramae Medical Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University Boramae Medical Center" #1 sponsor was "Seoul National University Hospital" with 25 trials, followed by "Kang Stem Biotech Co., Ltd." with 3 trials sponsored, "Seoul National University Boramae Hospital" with 3 trials sponsored, "Seung-Jung Park" with 3 trials sponsored and "Asan Medical Center" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University Boramae Medical Center" #1 collaborator was "SMG-SNU Boramae Medical Center" with 8 trials as a collaborator, "Seoul National University Bundang Hospital" with 5 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 4 trials as a collaborator, "Seoul National University Boramae Hospital" with 3 trials as a collaborator and "Seoul National University Hospital" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University Boramae Medical Center" are "Alzheimer's Disease" (3 trials), "Rheumatoid Arthritis" (3 trials), "Small Cell Lung Cancer" (3 trials), "Cerebral Infarction" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Seoul National University Boramae Medical Center" in a lesser frequency.

Most popular intervention types in "Seoul National University Boramae Medical Center" are "Drug" (38 trials), "Device" (7 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cilostazol" (3 trials), "Aspirin" (2 trials), "FURESTEM-RA Inj." (2 trials) and "Placebo for Naftopidil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University Boramae Medical Center" are 62 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seoul National University Boramae Medical Center". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Seoul National University Boramae Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University Boramae Medical Center, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 11 trials that are defined as “Not Applicable".

Seoul National University Boramae Medical Center has several departments that took part in Clinical trials: "SMG-SNU Boramae Medical Center - Oncology" - 3 trials